Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Cantor Fitzgerald
Medtronic
Fuji
Citi
Cerilliant
Accenture
Covington
Express Scripts

Generated: July 23, 2018

DrugPatentWatch Database Preview

CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

When do Cardene In 0.83% Sodium Chloride In Plastic Container patents expire, and what generic alternatives are available?

Cardene In 0.83% Sodium Chloride In Plastic Container is a drug marketed by Chiesi Usa Inc and is included in one NDA. There are four patents protecting this drug.

This drug has twenty-three patent family members in eleven countries.

The generic ingredient in CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER is nicardipine hydrochloride. There are eleven drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the nicardipine hydrochloride profile page.
Drug patent expirations by year for CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER
Medical Subject Heading (MeSH) Categories for CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER
Synonyms for CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER
1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid methyl 2-[methyl(phenylmethyl)amino]ethyl ester hydrochloride
1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)methyl-2-[methyl(phenylmethyl)amino]-3,5-pyridinedicarboxylic acid ethyl ester hydrochloride
1,4-Dihydro-2,6-dimethyl-4-[3-nitrophenyl]methyl-2-[methyl- (phenyl-methl)amino]-3,5- pyridinedicarboxylic acid ethyl ester
1,4-Dihydro-2,6-dimethyl-4-[3-nitrophenyl]methyl-2-[methyl-(phenyl-methl)amino]-3,5-pyridinedicarboxylic acid ethyl ester
2-(benzyl-methyl-amino)ethyl methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate hydrochloride
2-(Benzyl(methyl)amino)ethyl methyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)pyridine-3,5-dicarboxylate hydrochloride
2-(benzylmethylamino)ethl methyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate monohydrochloride
2-(Benzylmethylamino)ethyl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylatemonohydrochloride
2-(Benzylmethylamino)ethyl methyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate monohydrochloride
2-(N-benzyl-N-methylamino)ethyl methyl 2,6-dimethyl-4-(m-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate hydrochloride
2-[benzyl(methyl)amino]ethyl-methyl-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridin-3,5-dicarboxylathydrochlorid
2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid O3-methyl ester O5-[2-[methyl-(phenylmethyl)amino]ethyl] ester hydrochloride
3-(2-(benzyl(methyl)amino)ethyl) 5-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate hydrochloride
3-{2-[benzyl(methyl)amino]ethyl} 5-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate hydrochloride
3,5-pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 3-methyl 5-[2-[methyl(phenylmethyl)amino]ethyl] ester, hydrochloride (1:1)
3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, methyl 2-(methyl(phenylmethyl)amino)ethyl ester, monohydrochloride
3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-, 2-(benzylmethylamino)ethyl methyl ester, monohydrochloride
4- ?CHLORO- DIFLUORO- METHOXY) ? PHENYLAMINE
5-O-[2-[benzyl(methyl)amino]ethyl] 3-O-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate hydrochloride
5-O-[2-[benzyl(methyl)amino]ethyl] 3-O-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate;hydrochloride
527N843
54527-84-3
69441-18-5
A830225
AC1L253M
AC1Q67X4
AIKVCUNQWYTVTO-UHFFFAOYSA-N
AKOS015994734
AN-40518
Angioglebil
ANW-42546
BC201356
BCP9000988
Bionicard
C25H27N3O6.HCl
Cardene
Cardene In 0.86% Sodium Chloride In Plastic Container
Cardene In 4.8% Dextrose In Plastic Container
Cardene In 5.0% Dextrose In Plastic Container
Cardene SR
CAS-54527-84-3
CCG-39033
CCRIS 8508
CHEBI:7551
CHEMBL1200326
CHEMBL3199626
CPD004727071
CS-3684
CTK2F3563
D00617
Dafil
Dagan
DSSTox_CID_26992
DSSTox_GSID_46992
DSSTox_RID_82040
DTXSID9046992
EBD48801
EINECS 259-198-4
EINECS 274-007-4
EU-0100809
FT-0082866
FT-0630671
HMS1569M07
HMS1921H21
HY-12515A
KS-1276
Lincil
Loxen
LP00809
LS-131264
MFCD00057327
MLS000069782
MLS001146898
MLS002153279
MLS002153794
MolPort-003-666-362
N 7510
N0635
NC00578
NCGC00094142-01
NCGC00094142-02
NCGC00094142-03
NCGC00094142-04
NCGC00094142-05
NCGC00256289-01
NCGC00261494-01
NE54503
Nerdipine
Nicardil
Nicardipine (Hydrochloride)
Nicardipine for system suitability, European Pharmacopoeia (EP) Reference Standard
Nicardipine HCl
NICARDIPINE HYDROCHLORIDE
Nicardipine hydrochloride (JP17/USAN)
Nicardipine hydrochloride [USAN:JAN]
Nicardipine hydrochloride, European Pharmacopoeia (EP) Reference Standard
Nicardipine hydrochloride, powder, >=98%
Nicardipine hydrochloride, United States Pharmacopeia (USP) Reference Standard
nicardipine;
Nicardipinehydrochloride
Nicodel
NSC-757855
NSC757855
O3-methyl O5-[2-[methyl-(phenylmethyl)amino]ethyl] 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate hydrochloride
O5-[2-[benzyl(methyl)amino]ethyl] O3-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate hydrochloride
Opera_ID_357
Perdipina
Perdipine
Perpidine
Pharmakon1600-01501135
Prestwick_590
RS-69216
RS-69216-XX-07-0
RS-69216-XX-07-O
s4181
SAM002564254
SAM002643513
SCHEMBL41845
SMR000058487
SPECTRUM1501135
SR-01000075333
SR-01000075333-1
TN-901
Tox21_301832
Tox21_500809
TR-019279
W-105615
YC 93
YC-93
YC-93 hydrochloride

US Patents and Regulatory Information for CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Chiesi Usa Inc CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER nicardipine hydrochloride INJECTABLE;INTRAVENOUS 019734-004 Nov 7, 2008 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Chiesi Usa Inc CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER nicardipine hydrochloride INJECTABLE;INTRAVENOUS 019734-004 Nov 7, 2008 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Chiesi Usa Inc CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER nicardipine hydrochloride INJECTABLE;INTRAVENOUS 019734-004 Nov 7, 2008 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Chiesi Usa Inc CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER nicardipine hydrochloride INJECTABLE;INTRAVENOUS 019734-004 Nov 7, 2008 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Non-Orange Book US Patents for CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,659,290 Methods of preparing pre-mixed, ready-to-use pharmaceutical compositions ➤ Sign Up
9,549,994 Compositions of nicardipine and sulfoalkylated .beta.-cyclodextrin ➤ Sign Up
9,370,586 Methods of preparing pre-mixed, ready-to-use pharmaceutical compositions ➤ Sign Up
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Medtronic
QuintilesIMS
US Army
Cipla
Healthtrust
Boehringer Ingelheim
Baxter
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.